Chronic cough, defined as a cough lasting more than eight weeks, is a common and disruptive condition in clinical practice. Despite its prevalence, the diagnosis and treatment of chronic cough can be challenging due to its multifactorial nature, and the often complex interplay of underlying causes.
A systematic and comprehensive approach to diagnosis is imperative. History taking should focus on identifying common causes such as gastroesophageal reflux disease (GERD), upper airway cough syndrome (UACS), and non-asthmatic eosinophilic bronchitis (NAEB). A thorough physical examination, coupled with targeted investigations such as chest X-rays, spirometry, and bronchoprovocation tests, can aid in the identification of less common etiologies.
Empirical therapy based on the most likely diagnosis can be an effective initial approach. For instance, proton pump inhibitors for suspected GERD, or inhaled corticosteroids for NAEB. However, this approach requires careful patient follow-up to assess response and adjust treatment as necessary.
Emerging diagnostic tools, such as bronchial thermoplasty and impulse oscillometry, hold promise for the future. These tools can provide more precise information about airway inflammation and reactivity, potentially leading to more targeted treatments.
Ultimately, treatment should be individualized, addressing the underlying causes and taking into account patient preferences. This may involve pharmacological treatments, lifestyle modifications, or a combination of both. Refractory cases may benefit from multidisciplinary input, including pulmonology, gastroenterology, and otolaryngology expertise.
Chronic cough is a complex condition that requires a comprehensive diagnostic and therapeutic approach. By staying abreast of emerging diagnostic tools and maintaining a patient-centered focus, physicians can effectively manage this common, yet often challenging, condition.
1.
New drug combination shows good results in patients with HPV-negative head and neck cancer
2.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
3.
Asian Women With Breast Cancer Outlive White Peers
4.
What Comes After Cancer?
5.
An Examine More Into the Acceptance of CRISPR/Cas9 Gene Therapy for Sickle Cell Illness.
1.
Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment
2.
Spatial Transcriptomics in Oncology: Transforming Tumor Biology and Precision Medicine
3.
Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care
4.
Endurance Training in Hematologic Disease: Current Perspectives and Clinical Implications
5.
Cowden Syndrome and Cancer: Understanding the Risk Factors
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
3.
Understanding Common Causes of Abnormal Blood Counts
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
5.
Diagnosis and Management in Hematology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation